Skip to content

Clinical trials

Completed Observational Recurrence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Observational Status: Completed Clear all

225 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20011
20021
20032
20042
20057
20064
20078
20084
20099
20109
20115
20127
20134
201414
201518
201611
20179
201816
201914
202015
20219
202218
202310
20247
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed225

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb6
Celgene6
National Institute of Allergy and Infectious Diseases (NIAID)4
Zealand University Hospital4
AstraZeneca3
Duke University3
European Hepatocellular Cancer Liver Transplant Group3
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
National Taiwan University Hospital3
Samsung Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence225
Multiple Sclerosis15
Multiple Myeloma13
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Lymphoma9
Neoplasm Metastasis9
Lymphoma, Large B-Cell, Diffuse8
Neoplasms8
Disease Progression7
Breast Neoplasms6

Trials

Showing 1 to 25 of 225. Each trial links to its page on Pharma Observatory.

125 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.